The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Identification of tumor immune infiltration-associated lncRNAs for improving prognosis and immunotherapy response of patients with non-small cell lung cancer
Open accessAbstract
Background: Increasing evidence has demonstrated the functional relevance of long non-coding RNAs (lncRNAs) to immunity regulation and the tumor microenvironment in non-small cell lung cancer (NSCLC). However, tumor immune infiltration-associated lncRNAs and their value in improving clinical outcomes and immunotherapy remain largely unexplored. Methods: We developed a computational approach to identify an lncRNA signature (TILSig) as an indicator of immune cell infiltration in patients with NSCLC through integrative analysis for lncRNA, immune and clinical profiles of 115 immune cell lines, 187 NSCLC cell lines and 1533 patients with NSCLC. Then the influence of the TILSig on the prognosis and immunotherapy in NSCLC was comprehensively investigated. Results: Computational immune and lncRNA profiling analysis identified an lncRNA signature (TILSig) consisting of seven lncRNAs associated with tumor immune infiltration. The TILSig significantly stratified patients into the immune-cold group and immune-hot group in both training and validation cohorts. These immune-hot patients exhibit significantly improved survival outcome and greater immune cell infiltration compared with immune-cold patients. Multivariate analysis revealed that the TILSig is an independent predictive factor after adjusting for other clinical factors. Further analysis accounting for TILSig and immune checkpoint gene revealed that the TILSig has a discriminatory power in patients with similar expression levels of immune checkpoint genes and significantly prolonged survival was observed for patients with low TILSig and low immune checkpoint gene expression implying a better response to immune checkpoint inhibitor (ICI) immunotherapy. Conclusions: Our finding demonstrated the importance and value of lncRNAs in evaluating the immune infiltrate of the tumor and highlighted the potential of lncRNA coupled with specific immune checkpoint factors as predictive biomarkers of ICI response to enable a more precise selection of patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters
Yu, G., Wang, L.-G., Han, Y., & He, Q.-Y. (2012) · OMICS: A Journal of Integrative Biology · doi:10.1089/omi.2011.0118 · Cited by 36,259
Siegel, R. L., Miller, K. D., & Jemal, A. (2019) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21551 · Cited by 20,160
Exploration, normalization, and summaries of high density oligonucleotide array probe level data
Irizarry, R. A. (2003) · Biostatistics · doi:10.1093/biostatistics/4.2.249 · Cited by 10,603
The Immune Landscape of Cancer
Thorsson, V., Gibbs, D. L., Brown, S. D., Wolf, D., Bortone, D. S., Ou Yang, T.-H., Porta-Pardo, E., Gao, G. F., Plaisier, C. L., Eddy, J. A., et al. (2018) · Immunity · doi:10.1016/j.immuni.2018.03.023 · Cited by 5,870
Charoentong, P., Finotello, F., Angelova, M., Mayer, C., Efremova, M., Rieder, D., Hackl, H., & Trajanoski, Z. (2017) · Cell Reports · doi:10.1016/j.celrep.2016.12.019 · Cited by 5,041
The biology and management of non-small cell lung cancer
Herbst, R. S., Morgensztern, D., & Boshoff, C. (2018) · Nature · doi:10.1038/nature25183 · Cited by 4,891
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
Havel, J. J., Chowell, D., & Chan, T. A. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-019-0116-x · Cited by 2,286 · cited 6×
“By applying this computational frame to NSCLC cell line and patient data sets, we identified the lncRNA signature, named TILSig, as an indicator of immune cell infiltration in patients with NSCLC.”
InfluentialPagès, F., Mlecnik, B., Marliot, F., Bindea, G., Ou, F.-S., Bifulco, C., Lugli, A., Zlobec, I., Rau, T. T., Berger, M. D., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30789-x · Cited by 2,075
Cellular functions of long noncoding RNAs
Yao, R.-W., Wang, Y., & Chen, L.-L. (2019) · Nature Cell Biology · doi:10.1038/s41556-019-0311-8 · Cited by 1,386
Yanai, I., Benjamin, H., Shmoish, M., Chalifa-Caspi, V., Shklar, M., Ophir, R., Bar-Even, A., Horn-Saban, S., Safran, M., Domany, E., et al. (2005) · Bioinformatics · doi:10.1093/bioinformatics/bti042 · Cited by 1,300
Okayama, H., Kohno, T., Ishii, Y., Shimada, Y., Shiraishi, K., Iwakawa, R., Furuta, K., Tsuta, K., Shibata, T., Yamamoto, S., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-1403 · Cited by 874
Gene regulation in the immune system by long noncoding RNAs
Chen, Y. G., Satpathy, A. T., & Chang, H. Y. (2017) · Nature Immunology · doi:10.1038/ni.3771 · Cited by 697
Immunotherapy in Non–Small Cell Lung Cancer: Facts and Hopes
Doroshow, D. B., Sanmamed, M. F., Hastings, K., Politi, K., Rimm, D. L., Chen, L., Melero, I., Schalper, K. A., & Herbst, R. S. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-1538 · Cited by 667
Emerging functional and mechanistic paradigms of mammalian long non-coding RNAs
Moran, V. A., Perera, R. J., & Khalil, A. M. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks296 · Cited by 637
Rousseaux, S., Debernardi, A., Jacquiau, B., Vitte, A.-L., Vesin, A., Nagy-Mignotte, H., Moro-Sibilot, D., Brichon, P.-Y., Lantuejoul, S., Hainaut, P., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005723 · Cited by 586
Immunobiology of Long Noncoding RNAs
Atianand, M. K., Caffrey, D. R., & Fitzgerald, K. A. (2017) · Annual Review of Immunology · doi:10.1146/annurev-immunol-041015-055459 · Cited by 463
HYPE or HOPE: the prognostic value of infiltrating immune cells in cancer
Barnes, T. A., & Amir, E. (2017) · British Journal of Cancer · doi:10.1038/bjc.2017.220 · Cited by 432
Hu, G., Tang, Q., Sharma, S., Yu, F., Escobar, T. M., Muljo, S. A., Zhu, J., & Zhao, K. (2013) · Nature Immunology · doi:10.1038/ni.2712 · Cited by 406
Bense, R. D., Sotiriou, C., Piccart-Gebhart, M. J., Haanen, J. B. A. G., van Vugt, M. A. T. M., de Vries, E. G. E., Schröder, C. P., & Fehrmann, R. S. N. (2017) · Journal of the National Cancer Institute · doi:10.1093/jnci/djw192 · Cited by 379
Jochems, C., & Schlom, J. (2011) · Experimental Biology and Medicine · doi:10.1258/ebm.2011.011007 · Cited by 353
Immune Cell Composition in Human Non-small Cell Lung Cancer
Stankovic, B., Bjørhovde, H. A. K., Skarshaug, R., Aamodt, H., Frafjord, A., Müller, E., Hammarström, C., Beraki, K., Bækkevold, E. S., Woldbæk, P. R., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2018.03101 · Cited by 341
Ranzani, V., Rossetti, G., Panzeri, I., Arrigoni, A., Bonnal, R. J. P., Curti, S., Gruarin, P., Provasi, E., Sugliano, E., Marconi, M., et al. (2015) · Nature Immunology · doi:10.1038/ni.3093 · Cited by 334
Xu, M., Xu, X., Pan, B., Chen, X., Lin, K., Zeng, K., Liu, X., Xu, T., Sun, L., Qin, J., et al. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1063-6 · Cited by 290
Long noncoding RNA s as regulators of cancer immunity
Denaro, N., Merlano, M. C., & Lo Nigro, C. (2019) · Molecular Oncology · doi:10.1002/1878-0261.12413 · Cited by 185
Zhou, M., Zhao, H., Wang, Z., Cheng, L., Yang, L., Shi, H., Yang, H., & Sun, J. (2015) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-015-0219-5 · Cited by 179
Self-citationNoncoding RNA and its associated proteins as regulatory elements of the immune system
Turner, M., Galloway, A., & Vigorito, E. (2014) · Nature Immunology · doi:10.1038/ni.2887 · Cited by 174
Zhou, M., Guo, M., He, D., Wang, X., Cui, Y., Yang, H., Hao, D., & Sun, J. (2015) · Journal of Translational Medicine · doi:10.1186/s12967-015-0556-3 · Cited by 170
Self-citationDNA methylation–based immune response signature improves patient diagnosis in multiple cancers
Jeschke, J., Bizet, M., Desmedt, C., Calonne, E., Dedeurwaerder, S., Garaud, S., Koch, A., Larsimont, D., Salgado, R., den Eynden, G. V., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci91095 · Cited by 160
Bao, S., Zhao, H., Yuan, J., Fan, D., Zhang, Z., Su, J., & Zhou, M. (2019) · Briefings in Bioinformatics · doi:10.1093/bib/bbz118 · Cited by 153
Self-citationElling, R., Chan, J., & Fitzgerald, K. A. (2016) · European Journal of Immunology · doi:10.1002/eji.201444558 · Cited by 144
Multiparametric profiling of non–small-cell lung cancers reveals distinct immunophenotypes
Lizotte, P. H., Ivanova, E. V., Awad, M. M., Jones, R. E., Keogh, L., Liu, H., Dries, R., Almonte, C. G., Herter-Sprie, G. S., Santos, A. A., et al. (2016) · JCI Insight · doi:10.1172/jci.insight.89014 · Cited by 129
Hao, Y., Yan, M., Heath, B. R., Lei, Y. L., & Xie, Y. (2019) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1006976 · Cited by 120
Bonanno, L., Pavan, A., Dieci, M. V., Liso, E. D., Schiavon, M., Comacchio, G. M., Attili, I., Pasello, G., Calabrese, F., Rea, F., et al. (2018) · European Journal of Cancer · doi:10.1016/j.ejca.2018.06.023 · Cited by 112
Kulski, J. K. (2019) · Cells · doi:10.3390/cells8050480 · Cited by 98
Zhou, M., Zhao, H., Wang, X., Sun, J., & Su, J. (2018) · Briefings in Bioinformatics · doi:10.1093/bib/bby021 · Cited by 97
Self-citationVarn, F. S., Tafe, L. J., Amos, C. I., & Cheng, C. (2018) · OncoImmunology · doi:10.1080/2162402x.2018.1431084 · Cited by 72
Erratum: HYPE or HOPE: the prognostic value of infiltrating immune cells in cancer
Barnes, T. A., & Amir, E. (2018) · British Journal of Cancer · doi:10.1038/bjc.2017.417 · Cited by 69
Gridelli, C., Ardizzoni, A., Barberis, M. C. P., Cappuzzo, F., Casaluce, F., Danesi, R., Troncone, G., & de Marinis, F. (2017) · Translational Lung Cancer Research · doi:10.21037/tlcr.2017.05.09 · Cited by 65
The paradoxical role of tumor-infiltrating immune cells in lung cancer
Zheng, X., Hu, Y., & Yao, C. (2017) · Intractable & Rare Diseases Research · doi:10.5582/irdr.2017.01059 · Cited by 65
Pu, X., Wu, L., Su, D., Mao, W., & Fang, B. (2018) · BMC Cancer · doi:10.1186/s12885-018-4990-5 · Cited by 58
Characterization of Transcriptome Transition Associates Long Noncoding RNAs with Glioma Progression
Li, X., Jiang, T., Bai, J., Li, J., Wang, T., Xiao, J. Y., Tian, Y., Jin, X., Shao, T., Xu, J., et al. (2018) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2018.10.009 · Cited by 48
Wang, L., Felts, S. J., Keulen, V. P. V., Scheid, A. D., Block, M. S., Markovic, S. N., Pease, L. R., & Zhang, Y. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-0529 · Cited by 28
Korsunsky, I., Parameswaran, J., Shapira, I., Lovecchio, J. L., Menzin, A. W., Whyte, J. S., Santos, L. D., Liang, S. X., Bhuiya, T. A., Keogh, M., et al. (2017) · Journal of Investigative Medicine · doi:10.1136/jim-2017-000457 · Cited by 20
Mansuet‐Lupo, A., Alifano, M., Wislez, M., Boulle, G., Velut, Y., Biton, J., Cremer, I., Goldwasser, F., Leroy, K., & Damotte, D. (2018) · Revue de Pneumologie Clinique · doi:10.1016/j.pneumo.2018.09.010 · Cited by 8
Metadata
- Authors
- Sun, J., Zhang, Z., Bao, S., Yan, C., Hou, P., Wu, N., Su, J., Xu, L., & Zhou, M.
- Venue
- Journal for ImmunoTherapy of Cancer
- Publisher
- BMJ
- Published
- 2020-02
- Volume
- 8
- Issue
- 1
- Pages
- e000110
- ISSN
- 2051-1426 (ISSN-L)
- OpenAlex
- W3006273887
- Cited by
- 291
- References
- 44
- FWCI
- 17.76
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.